GUADALUPE DOMINGUEZ: Open Payments
NPI 1649268913 · NORTH LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,777 in 97 payments from 15 companies in 2025. Trend: 2023 $251 · 2024 $1,247 · 2025 $1,777
Food & beverage: $1,777
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $707 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $178 |
| Janssen Biotech, Inc. | 13 | $176 |
| GENZYME CORPORATION | 14 | $145 |
| Gilead Sciences, Inc. | 7 | $135 |
| Madrigal Pharmaceuticals | 4 | $105 |
| Aimmune Therapeutics, Inc. | 4 | $81 |
| PFIZER INC. | 3 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Braintree Laboratories, Inc. | 2 | $32 |
Products named: RINVOQ, SKYRIZI, TREMFYA, DUPIXENT, CREON, REZDIFFRA, RELISTOR, VELSIPITY.
Industry payments across NV — which companies pay providers there.
